Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

Mar­i­nus Phar­ma­ceu­ti­cals is re­duc­ing its work­force again and tak­ing oth­er mea­sures to re­duce costs af­ter its ...

Zai Lab released Phase 1a data Thursday morning as it attempts to compete with a recently approved Amgen drug. The program, ...

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

MGM Resorts plans to stop covering GLP-1 weight loss shots for its employees next year, after it faced constraints in what it ...

GSK is presenting its case for broader use of its RSV vaccine with new data from a pair of studies in younger adults with ...

Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...

Precision Biosciences has received clearance from regulators in the Eastern European country of Moldova to begin a human ...

The promise of a one-and-done CRISPR in­fu­sion is be­gin­ning to look more re­al than ever. On Thurs­day, In­tel­lia ...

Plus, news about Interius BioTherapeutics, Hope Medicine, PMV Pharmaceuticals, Epitopea, Alyssum Therapeutics and a new dementia trial accelerator in the UK: Bayer exercises option to develop heart ...

Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...

More people are now advised to get a pneumococcal vaccine if they haven’t already, as CDC advisors recommended the shots for ...